Please find attached the Notice of the 37th Annual General Meeting of the Company

Date: 04-09-2026 To To The General Manager The Manager Department of Corporate Services Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Tower Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Mumbai - 400 051 Scrip Code at BSE: 533259 Symbol at NSE: HEALTHX Subject: Notice of the 37th Annual General Meeting of the Company Dear Sir/ Madam, Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice of the 37th Annual General Meeting of the members of the Company scheduled to be held on Monday, the 28th September, 2026 at 3.00 P.M. (IST) through Video Conferencing (“VC”) or Other Audio Visual Means (“OAVM”) to transact the business as set out in the notice convening the AGM. The Notice is being sent through electronic mode to those Members whose e-mail addresses are registered with the Company/Registrar and Share Transfer Agent/Depositories. The aforesaid Notice of Annual General Meeting is also available on the Company’s website at www.healthxplatform.com. You are requested to kindly take the same on record. Thanking you, Yours faithfully, For Health X Platform Limited (formerly known as Sastasundar Ventures Limited) Pratap Singh Company Secretary & Compliance Officer M. No.: A24081 Encl: As above HEALTH X PLATFORM LIMITED (formerly known as Sastasundar Ventures Limited) CIN: L65993WB1989PLC047002 Registered Office: Azimganj House, 2nd Floor, 7 Abanindra Nath Thakur Sarani (Formerly Camac Street), Kolkata -700017 • Ph: (033) 2282 9330 Email: investors@sastasundar.com • Website: www.healthxplatform.com NOTICE OF ANNUAL GENERAL MEETING NOTICE is hereby given that the Thirty-seventh (37th) Annual General Meeting (AGM) of the Members of Health X Platform Limited (formerly known as Sastasundar Ventures Limited) will be held on Monday, the 28th day of September, 2026 at 3.00 P.M. (IST) through Video Conferencing (“VC”) or Other Audio Visual Means (“OAVM”) to transact the following business: ORDINARY BUSINESS: 1. To receive, consider and adopt the Audited Financial Statements (both Standalone and Consolidated) of the Company for the financial year ended 31st March, 2026, together with Report of the Board of Directors and Auditors thereon. 2. To appoint a Director in place of Mrs. Abha Mittal (DIN: 00519777) who retires by rotation, and being eligible offers herself for re-appointment. SPECIAL BUSINESS: 3. Re-appointment of Mrs. Anjana Dikshit (DIN - 10377490) as an Independent Director of the Company for the second term of 5 (five) consecutive years: To consider and if thought fit, to pass, with or without modification(s), the following resolution as a Special Resolution: “RESOLVED THAT pursuant to the provisions of Sections 149, 150 and 152, Schedule IV and other applicable provisions, if any, of the Companies Act, 2013 (the Act) and the Rules made thereunder and the applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) (including any statutory modification(s) or re-enactment thereof for the time being in force), the provisions of the Articles of Association of the Company and based on the recommendations of the Nomination and Remuneration Committee and the Board of Directors of the Company, approval of the Members be and is hereby accorded for re-appointment of Mrs. Anjana Dikshit (DIN - 10377490), who has submitted a declaration that she meets the criteria of independence under Section 149(6) of the Act and Regulation 16(1)(b) of the Listing Regulations and is eligible for re-appointment under the provisions of the Act, the Rules made thereunder and the Listing Regulations, as an Independent Director, not liable to retire by rotation, to hold office for a second term of five consecutive years i.e., from November 10, 2026 upto November 9, 2031. RESOLVED FURTHER THAT the Board or any duly constituted Committee of the Board, be and is hereby authorised to do all acts, deeds, matters and things as may be deemed necessary and/or expedient in connection therewith or incidental thereto, to give effect to the foregoing resolution.” 4. To approve the overall borrowing limit of the Company under Section 180(1)(c) of the Companies Act, 2013: To consider and if thought fit, to pass, with or without modification(s), the following resolution as a Special Resolution: “RESOLVED THAT pursuant to the provisions of Section 180(1)(c) and other applicable provisions, if any, of the Companies Act, 2013 (“Act”) read with the Rules made thereunder (including any statutory modification(s), amendment(s) or re- enactment(s) thereof for the time being in force), the Articles of Association of the Company and subject to such other approvals, consents and permissions as may be required under the Act and other applicable laws, the consent of the Members be and is hereby accorded to the Board of Directors of the Company (hereinafter referred to as the “Board”, which term shall be deemed to include any Committee thereof or any person(s) authorised by the Board) to borrow, from time to time, any sum or sums of money (including fund-based and/or non-fund-based facilities), by way of loans, cash credit, overdraft facilities, lines of credit, commercial papers, debentures, external commercial borrowings, inter-corporate deposits or any other debt instruments or financial facilities, from banks, financial institutions, bodies corporate, investors or other eligible lenders, with or without security, on such terms and conditions as the Board may deem fit, provided that HEALTH X PLATFORM LIMITED 1 the aggregate amount of monies so borrowed and outstanding at any time (apart from temporary loans obtained from the Company’s bankers in the ordinary course of business) shall not exceed Rs. 500 Crores (Rupees Five Hundred Crores Only) outstanding at any time; RESOLVED FURTHER THAT the Board be and is hereby authorised to delegate all or any of the powers conferred upon it by this Resolution to any Committee of the Board, Director(s), Key Managerial Personnel or any other officer(s) of the Company, on such terms and conditions as it may deem fit, for the purpose of giving effect to this Resolution; RESOLVED FURTHER THAT the Board and/or any person(s) authorised by the Board be and are hereby severally authorised to do all such acts, deeds, matters and things, execute all agreements, deeds, documents and writings, make necessary filings with statutory, regulatory authorities, and take all such steps as may be necessary, proper, desirable, incidental or expedient to give effect to this Resolution, including settling any question, difficulty or doubt that may arise in connection therewith.” 5. To seek approval under Section 180(1)(a) of the Companies Act, 2013 inter-alia for creation of mortgage or charge on the assets, properties or undertaking(s) of the Company: To consider and if thought fit, to pass, with or without modification(s), the following resolution as a Special Resolution: “RESOLVED THAT pursuant to the provisions of Section 180(1)(a) of the Companies Act, 2013 (“Act”) and other applicable provisions, if any, read with the Rules made thereunder (including any statutory modification(s), amendment(s) or re- enactment(s) thereof), the Articles of Association of the Company and subject to such approvals, consents and permissions as may be required under the Act and other applicable laws, the consent of the Members be and is hereby accorded to the Board of Directors of the Company (hereinafter referred to as the “Board”, which term shall be deemed to include any Committee thereof or any person(s) authorised by the Board) to create, in addition to the existing security interests, such mortgage(s), charge(s), hypothecation(s), pledge(s), lien(s), assignment(s), floating charge(s) or any other security interest(s), in such form and manner and on such t [Showing first 8,000 characters — download PDF for full document]